CLCR Call: April 5, 2021

For Public Health

At a glance

The April 5, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and testing, and an FDA update.

Format: MP3
Language: English (US)
Size: 20 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing: Richard Creager, NIH RADx Variant Task Force

Saliva-Based SARS-CoV-2 Testing Data: Anne Wyllie, Yale University

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: April 5, 2021

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: April 5, 2021

The information on this page was last reviewed by subject matter experts to ensure accuracy.